Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Moderna Inc
(NQ:
MRNA
)
142.55
-8.94 (-5.90%)
Official Closing Price
Updated: 4:15 PM EDT, May 31, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Moderna Inc
< Previous
1
2
...
6
7
8
9
10
11
12
13
Next >
Moderna and South Korea Explore Collaboration on mRNA Vaccines
May 22, 2021
From
Moderna, Inc.
Via
Business Wire
Ministry of Food and Drug Safety of South Korea (MFDS) Authorizes Moderna’s COVID-19 Vaccine
May 21, 2021
From
Moderna, Inc.
Via
Business Wire
Japan’s Ministry of Health, Labour and Welfare (MHLW) Approves Moderna’s COVID-19 Vaccine
May 21, 2021
From
Moderna, Inc.
Via
Business Wire
Moderna to Host Fourth Annual Science Day on May 27, 2021
May 19, 2021
From
Moderna, Inc.
Via
Business Wire
Moderna to Establish an International Business Services Hub in Warsaw, Poland
May 19, 2021
From
Moderna, Inc.
Via
Business Wire
Moderna Announces New Supply Agreement with Australia for 25 Million Doses of its COVID-19 Vaccine
May 12, 2021
From
Moderna, Inc.
Via
Business Wire
Moderna to Present at the Bank of America 2021 Healthcare Conference
May 07, 2021
From
Moderna, Inc.
Via
Business Wire
Moderna Reports First Quarter Fiscal Year 2021 Financial Results and Provides Business Updates
May 06, 2021
From
Moderna, Inc.
Via
Business Wire
Moderna Announces New Supply Agreement with Switzerland for 7 Million Booster Vaccine Doses in 2022 and Option for Additional 7 Million Doses
May 06, 2021
From
Moderna, Inc.
Via
Business Wire
Moderna Announces Positive Initial Booster Data Against SARS-CoV-2 Variants of Concern
May 05, 2021
From
Moderna, Inc.
Via
Business Wire
Moderna Announces Expansion of its Manufacturing Technology Center in Massachusetts
May 04, 2021
From
Moderna, Inc.
Via
Business Wire
Moderna Announces Supply Agreement with Gavi for up to 500 Million Doses of COVID-19 Vaccine Moderna for COVAX To Help End COVID-19 Pandemic in Lowest Income Countries
May 03, 2021
From
Moderna, Inc.
Via
Business Wire
Moderna Announces Emergency Use Listing Granted by the World Health Organization for its COVID-19 Vaccine
April 30, 2021
From
Moderna, Inc.
Via
Business Wire
Moderna Announces Additional Investments to Increase Global Supply for COVID-19 Vaccine to up to 3 Billion Doses in 2022
April 29, 2021
From
Moderna, Inc.
Via
Business Wire
Moderna Announces Agreement with Sanofi for Fill/Finish Manufacturing of the Moderna COVID-19 Vaccine in the U.S.
April 26, 2021
From
Moderna, Inc.
Via
Business Wire
Moderna Announces New Supply Agreement with Israel for 2022
April 20, 2021
From
Moderna, Inc.
Via
Business Wire
Moderna to Report First Quarter Financial Results on Thursday, May 6, 2021
April 16, 2021
From
Moderna, Inc.
Via
Business Wire
Moderna Announces Clinical Progress from its Industry-Leading mRNA Vaccine Franchise and Continues Investments to Accelerate Pipeline Development
April 14, 2021
From
Moderna, Inc.
Via
Business Wire
Moderna Provides Clinical and Supply Updates on COVID-19 Vaccine Program Ahead of 2nd Annual Vaccines Day
April 13, 2021
From
Moderna, Inc.
Via
Business Wire
Moderna to Present at the 20th Annual Needham Virtual Healthcare Conference
April 09, 2021
From
Moderna, Inc.
Via
Business Wire
Moderna Highlights Publication of Antibody Persistence Data of its COVID-19 Vaccine out to 6 Months in the New England Journal of Medicine
April 07, 2021
From
Moderna, Inc.
Via
Business Wire
< Previous
1
2
...
6
7
8
9
10
11
12
13
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.